Navigation Links
GlaxoSmithKline to Grant $400,000 to Healthcare Nonprofits at Annual IMPACT Awards
Date:10/25/2011

DURHAM, N.C., Oct. 25, 2011 /PRNewswire/ -- GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, today announced the 10 winners of its GlaxoSmithKline IMPACT Awards. In total, the North Carolina and Philadelphia-area healthcare nonprofit organizations will receive $400,000 in grant funding for providing access to healthcare for the underserved in their communities.

Three of the North Carolina recipients listed below are based in counties that became eligible for a GlaxoSmithKline IMPACT Award for the first time in 2011 -- Alamance, Lee and Moore.

"All of the GlaxoSmithKline IMPACT Award winners are leaders in the nonprofit world and in their communities," said Mary Linda Andrews, GlaxoSmithKline Director of Community Partnerships. "The dedicated teams of professionals and volunteers at these organizations are working on the front lines to provide access to healthcare at a time when people need it most. These awards provide additional resources to help them continue their important work."

Grants were awarded to the following organizations:

The Healing Place of Wake County - Raleigh, N.C., Wake County

Helping Hand Clinic Inc. - Sanford, N.C., Lee County

Housing for New Hope, Inc. - Durham, N.C., Durham County

Legal Clinic for the Disabled, Inc. - Philadelphia, Pa.

Moore Free Care Clinic, Inc. - Southern Pines, N.C., Moore County

North Carolina Therapeutic Riding Center, Inc. - Mebane, N.C., Alamance County

Phoenixville Healthcare Access Foundation -  Phoenixville, Pa., Chester County

Senior PharmAssist, Inc. - Durham, N.C., Durham County

Support Center for Child Advocates - Philadelphia, Pa.

Water Street Health Services - Lancaster, Pa., Lancaster County

In North Carolina, GlaxoSmithKline works in partnership with Durham-based Triangle Community Foundation (TCF), a nonprofit that connects resources with needs through community-based philanthropy. TCF and GlaxoSmithKline identified potential nonprofit applicants, encouraged their participation and promoted the awards through grassroots outreach.

"It is essential that nonprofit organizations have the resources they need to address ever-increasing demands for their services, especially in the world of healthcare," said Lori O'Keefe, TCF Vice President for Philanthropic Services and COO. "Our partnership with GlaxoSmithKline highlights the dedication of these nonprofits and will encourage others to participate in the future as we strive toward excellence in healthcare access."

The GlaxoSmithKline IMPACT Awards (whose name represents Innovation, Management, Partnership, Achievement, Community focus and Targeting needs of diverse and underserved populations) honor nonprofit organizations that have a significant impact on their communities and are capable, proactive and effective in their work. This year's winners will receive their GlaxoSmithKline IMPACT Awards at separate ceremonies held at GlaxoSmithKline's headquarters in Research Triangle Park, N.C. and in Philadelphia.

To qualify for a GlaxoSmithKline IMPACT award, organizations must be located in the eligible counties and have a primary mission to provide access to community healthcare services. Each applicant must have annual total operating expenses between $160,000 and $3 million, and have been in existence as a 501(c)(3) nonprofit organization for at least five years.

All organizations are recognized for the success and achievements of their existing overall body of work, not just for new or specific initiatives. A panel of healthcare delivery experts and GlaxoSmithKline representatives determine the winners based on a strong demonstration of ongoing success in providing access to healthcare, commitment to serving people in need, facilitation of healthcare delivery, creative partnerships and policy development, and a solid record of achievement, management and leadership.  

About GlaxoSmithKline

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline on the World Wide Web at us.gsk.com.   

About Triangle Community Foundation

Triangle Community Foundation, a nonprofit organization that manages $145 million in funds established by individuals, businesses and families, makes grants to nonprofit organizations and administers a variety of programs for the community's benefit. The Foundation currently manages over 755 funds, ranging in size from $10,000 to $10 million, primarily for the benefit of Wake, Durham, Orange and Chatham counties. During the 2010-11 fiscal year, TCF granted more than $14 million to nonprofits, schools and community efforts. On average, it distributes more than 10% of its assets each year, raising the total value of grants made since the Foundation's inception in 1983 to over $173 million. For more information, please visit www.trianglecf.org.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Donates Scientific Equipment to Advance IDRIs Global Health Mission
2. GlaxoSmithKline CEO and CFO Interviewed on Q2 2011 Results
3. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
4. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
5. GlaxoSmithKline Confirms allis Safety Profile
6. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
7. GlaxoSmithKline Wins Environmental Stewardship Award
8. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
9. GlaxoSmithKline Applauds North Carolinas Child Advocates
10. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
11. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s ... Sunday, with sunny skies, a light breeze and temperatures in the 60s. Over 400 ... 5k Run and Walk and 1-mile walk were held to increase awareness about ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 Wharton ... Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award for Most ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. ... for the majority of skin cancer deaths. More than 10,000 people are expected to die ... diagnosis is 62, it is the one of the most commonly diagnosed cancers in young ...
Breaking Medicine News(10 mins):